These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29474204)

  • 41. [The JAK2 mutation in myeloproliferative disorders: A predictive factor of thrombosis].
    Mahjoub S; Baccouche H; Sahnoun M; Kaabi H; Manai Z; Slama H; Ben Romdhane N
    Tunis Med; 2015 Jul; 93(7):474-7. PubMed ID: 26757507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician survey.
    Ellis MH; Lavi N; Vannucchi A; Harrison C
    Thromb Res; 2014 Aug; 134(2):251-4. PubMed ID: 24842684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases.
    Vignal CV; Lourenço DM; Noguti MA; Chauffaille Mde L; Kerbauy J
    Sao Paulo Med J; 1997; 115(6):1575-9. PubMed ID: 9640794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
    Kaifie A; Isfort S; Gattermann N; Hollburg W; Klausmann M; Wolf D; Maintz C; Hänel M; Goekkurt E; Göthert JR; Platzbecker U; Geer T; Parmentier S; Jost E; Serve H; Ehninger G; Berdel WE; Brümmendorf TH; Koschmieder S;
    Ann Hematol; 2016 Sep; 95(9):1399-410. PubMed ID: 27334946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.
    Hultcrantz M; Björkholm M; Dickman PW; Landgren O; Derolf ÅR; Kristinsson SY; Andersson TML
    Ann Intern Med; 2018 Mar; 168(5):317-325. PubMed ID: 29335713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide.
    Schwarz J; Ovesná P; Černá O; Kissová J; Maaloufová Soukupová J; Brychtová Y; Doubek M; Červinek L; Cmunt E; Dulíček P; Campr V; Křen L; Penka M;
    Eur J Haematol; 2016 Jan; 96(1):98-106. PubMed ID: 25807961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of cesarean section on mean platelet volume.
    Usluoğullari B; Kaygusuz I; Simavli S; Eser A; Inegol Gumus İ
    Platelets; 2015; 26(7):657-60. PubMed ID: 25350688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients.
    Baccouche H; Ben Jemaa M; Chakroun A; Chadi S; Mahjoub S; Sfar I; Gorgi Y; Ben Romdhane N
    Int J Lab Hematol; 2017 Oct; 39(5):502-507. PubMed ID: 28497580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis.
    Mutlu H; Artis TA; Erden A; Akca Z
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):331-3. PubMed ID: 22345488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms.
    Enblom A; Lindskog E; Hasselbalch H; Hersby D; Bak M; Tetu J; Girodon F; Andréasson B
    Eur J Intern Med; 2015 Jun; 26(5):344-7. PubMed ID: 25863408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.
    Ball S; Thein KZ; Maiti A; Nugent K
    J Thromb Thrombolysis; 2018 May; 45(4):516-528. PubMed ID: 29404876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events.
    Lim HY; Ng C; Donnan G; Nandurkar H; Ho P
    J Thromb Thrombolysis; 2016 Oct; 42(3):423-31. PubMed ID: 27085541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience.
    Kissova J; Ovesna P; Bulikova A; Zavřelova J; Penka M
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):448-53. PubMed ID: 25828967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?
    Korkmaz S; Uslu AU; Sahin S; Senel S; Sencan M
    Platelets; 2014; 25(5):343-7. PubMed ID: 23971949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms.
    Potthoff A; Attia D; Pischke S; Mederacke I; Beutel G; Rifai K; Deterding K; Heiringhoff K; Klempnauer J; Strassburg CP; Manns MP; Bahr MJ
    Liver Int; 2015 Aug; 35(8):2042-9. PubMed ID: 25736096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
    Landolfi R; Marchioli R; Patrono C
    Thromb Haemost; 1997 Jul; 78(1):617-21. PubMed ID: 9198226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.
    Schmidt S; Daniliants D; Hiller E; Gunsilius E; Wolf D; Feistritzer C
    Blood Adv; 2021 Sep; 5(18):3515-3527. PubMed ID: 34464975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.
    Dentali F; Ageno W; Rumi E; Casetti I; Poli D; Scoditti U; Maffioli M; di Minno MN; Caramazza D; Pietra D; De Stefano V; Passamonti F
    Thromb Res; 2014 Jul; 134(1):41-3. PubMed ID: 24787989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelide.
    Ahn IE; Natelson E; Rice L
    Clin Lymphoma Myeloma Leuk; 2013 Sep; 13 Suppl 2():S300-4. PubMed ID: 24290215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Mean Platelet Volume Is Decreased in Patients Diagnosed with Venous Thromboembolism in the Emergency Department.
    Lippi G; Buonocore R; Cervellin G
    Semin Thromb Hemost; 2016 Sep; 42(6):632-5. PubMed ID: 27074441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.